Chemical Structure : CX1003
货号: PC-26906Not For Human Use, Lab Use Only.
CX1003 is a novel multitargeted receptor tyrosine kinase inhibitor targeting MET and VEGFR types 2 (VEGFR-2, KDR), also possesses inhibitory activities against several other kinases, such as Ret.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CX1003 is a novel multitargeted receptor tyrosine kinase inhibitor targeting MET and VEGFR types 2 (VEGFR-2, KDR), also possesses inhibitory activities against several other kinases, such as Ret.
CX1003 has exhibited great potential for antitumor effects in various in vitro and animal studies.
CX1003 induced tumor regressions in xenograft mouse models derived from human gastric cell GTL16, human glioma cell U87MG and significantly decreased bone metastasis in ARCaPM prostate cancer models.
| 分子量 | 752.75 | |
| 分子式 | C38H43F2N4O8P | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Li Y, et al. Bioanalysis. 2019 Aug;11(16):1483-1493.
2. Patent CN102093421B.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright